Success Stories: Staff Scientist in the Field of Immunology from Russia Earns NIW without RFE
Client’s Testimonial:
“Chen Law firm provided exceptional service throughout my case. Thanks to their hard work, I was able to achieve approval for my case.”
On October 28th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Staff Scientist in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Staff Scientist
Country of Origin: Russia
State of Residence at the Time of Filing: Missouri
Approval Notice Date: October 28th, 2025
Processing Time: 18 months, 24 days (Premium Processing Upgrade Requested)
Case Summary:
Our firm is pleased to share that an NIW (National Interest Waiver) petition for a staff scientist in the field of immunology from Russia has been approved. Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling petition for this staff scientist specializing in inflammatory responses, immune aging, and therapeutic target discovery.
The client holds an M.D. and an M.S. in bioinformatics and systems biology. The proposed endeavor, to discover the underlying mechanisms driving inflammatory processes linked to diseases and aging by analyzing complex immunological multi-omics data to identify novel therapeutic targets, addresses urgent national priorities, including cancer immunotherapy and neurodegenerative diseases. The petition was submitted on April 5, 2024, and received approval 18 months after filing (and shortly after the upgrade to premium processing), without an RFE.
Strategic Petition Development
In preparing the petition, North America Immigration Law Group (NAILG) emphasized that chronic inflammatory diseases affect nearly 60% of Americans, with Alzheimer’s disease cases projected to reach 13.8 million by 2060. The client’s research directly supports efforts to reduce healthcare costs that burden the United States by hundreds of billions of dollars annually. We also highlighted alignment with critical and emerging technologies identified by the National Science and Technology Council, specifically in advancing multi-omics and bioinformatics, which are essential to U.S. technological leadership.
To demonstrate the client was well-positioned to advance this endeavor, we assembled comprehensive evidence:
-
6 peer-reviewed journal articles (1 first-authored) and 3 conference abstracts (2 first-authored)
-
35 citations demonstrating significant early-career influence
-
At least 4 papers ranking among the most highly cited in Immunology for their publication year (top 0.1%, 1%, 10%, and 20% respectively)
-
The research was supported by four separate funding sources.
Powerful Expert Validation
We secured four expert recommendation letters. One independent expert emphasized:
“In sum, [The Client]’s contributions to the field of immunology hold great merit for improving health and economic outcomes in the United States. [The Client]’s successful development of a comprehensive simulation to identify dysfunction signatures in CAR T-cells directly supports the improvement of cancer therapeutics, thus confirming the need for her continued work in the United States.”
Successful Outcome
This successful outcome underscores NAILG’s dedication to representing accomplished scientists whose work has transformative implications for healthcare and human longevity. We are honored to have supported this extraordinary researcher and extend our sincere best wishes for continued success in advancing immunology research that will benefit countless Americans.